Starch modified alginate nanoparticles for drug delivery application

Int J Biol Macromol. 2021 Mar 15:173:277-284. doi: 10.1016/j.ijbiomac.2020.12.227. Epub 2021 Jan 13.

Abstract

Natural polymers have been widely studied as vehicles that have gained much interest in the encapsulation and delivery of drugs and bioactive molecules. In this study, we developed starch-modified alginate nanoparticles using a green facile technique for drug delivery application. The potential of the prepared nanoparticles for controlled drug delivery applications is demonstrated using theophylline and bovine serum albumin as model drugs. The nanoparticles possessed the encapsulation efficiency of 60 to 75%. The results of in vitro drug release studies showed the pH dependent characteristics of the prepared nanoparticles. In vitro cytotoxicity test revealed the biocompatibility of the developed nanoparticles against L929 fibroblast cell lines. The in vitro cellular uptake of nanoparticles was visualized in L929 fibroblast cells using fluorescent microscopy. The preliminary investigation suggests the developed nanoparticle is a promising candidate for drug delivery application.

Keywords: Alginate; Bovine serum albumin; Drug delivery; Starch; Theophylline.

MeSH terms

  • Alginates / chemistry*
  • Animals
  • Capsules
  • Cattle
  • Cell Line
  • Drug Delivery Systems
  • Hydrogen-Ion Concentration
  • Mice
  • Microscopy, Fluorescence
  • Nanoparticles
  • Serum Albumin, Bovine / chemistry*
  • Serum Albumin, Bovine / pharmacology
  • Starch / chemistry*
  • Theophylline / chemistry*
  • Theophylline / pharmacology

Substances

  • Alginates
  • Capsules
  • Serum Albumin, Bovine
  • Starch
  • Theophylline